Mantova, Italy

Marco Frigerio


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1985-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Marco Frigerio: Innovating in Chemistry

Introduction

Marco Frigerio is an accomplished inventor based in Mantova, Italy. He has made significant contributions to the field of chemistry, particularly in the development of new chemical compounds and processes. With a total of four patents to his name, Frigerio's work showcases his dedication to innovation and research.

Latest Patents

Frigerio's latest inventions focus on 3-aminoazetidine and its salts. His patents detail a comprehensive process for the preparation of 3-aminoazetidine, starting from a 1-protected 3-sulfonyloxyazetidine. The methodology involves a reaction with potassium phthalimide to yield new intermediates, characterized by a specific formula where certain groups such as hydrogen or protecting groups play a crucial role. His contributions include "3-aminoazetidine, its salts, process for their preparation," and related intermediates that hold potential applications in various industrial sectors.

Career Highlights

Throughout his career, Marco Frigerio has worked with leading pharmaceutical companies, including Sanofi and Société Anonyme Sanofi. His tenure in these organizations has allowed him to apply his inventive skills in practical settings, contributing to the broader pharmaceutical landscape.

Collaborations

In his professional journey, Frigerio has collaborated with notable coworkers such as Dino Nisato and Giovanna F Miranda. These collaborations have undoubtedly enhanced the quality and breadth of his innovative projects, highlighting the importance of teamwork in the field of research and development.

Conclusion

Marco Frigerio's contributions to the field of chemistry through his patents demonstrate his commitment to innovation and his ability to create valuable chemical processes and compounds. His work not only reflects his expertise as an inventor but also underscores the collaborative nature of scientific progression in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…